ABO-incompatible living donor kidney transplantation under tacrolimus immunosuppression.
Tanabe
K
K
Section of Renal Transplantation/Renovascular Surgery, Department of Urology, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.
Tokumoto
T
T
Ishikawa
N
N
Shimizu
T
T
Okuda
H
H
Ito
S
S
Shimmura
H
H
Inui
M
M
Harano
M
M
Manu
M
M
Shiroyanagi
Y
Y
Yagisawa
T
T
Nakajima
I
I
Fuchinoue
S
S
Toma
H
H
D000017:ABO Blood-Group System; D000293:Adolescent; D000328:Adult; D001787:Blood Group Incompatibility; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D015996:Survival Rate; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D000017:ABO Blood-Group System; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus